There is a new eye injection that has been showing early success in helping people with a rare inherited blindness that is called "Leber Congenital Amaurosis". LCA is caused by a mutation in the centrosomal protein 290 gene. Which end up causing malfunctions in the retina's rode and cones.
The article talks more about how researchers have made a small trial that included about 14 participants and 11 of those participants got better vision in one eye after getting a single injection. This was one of the first times a gene-editing treatment was used on people with congenital blindness. Using the CRISPR treatment for LCA patients during the year 2020, left many people happy with how their vision improved.
Yet, the clinical trial went to a pause in November 2022 to find new commercial partners to further their research and development on the treatment to continue their work.
It seems gene therapy is beginning to be studied for all different types of inherited diseases, and it seems to be very promising in most trials.
ReplyDelete